Curevac AG

How an mRNA Vaccine Targets Prostate Cancer with Six Antigens

This patent describes an mRNA vaccine designed to treat prostate cancer by delivering genetic instructions for a specific combination of six prostate-related proteins, teaching the body to fight the cancer.

How an mRNA Vaccine for Lung Cancer Teaches the Immune System to Fight

This patent describes a specific mRNA vaccine designed to treat lung cancer by instructing the body's cells to produce six distinct tumor proteins, thereby training the immune system to recognize and attack cancer cells.

Using Two Specific RNAs to Teach the Body to Fight Lung Cancer

This patent describes an active composition containing two specific messenger RNAs, NY-ESO-1 and MAGE-A3, designed to stimulate an immune response in a mammal to treat lung cancer, especially non-small cell lung cancers.